You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 2, January 10, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Preliminary Communication
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Otolaryngology/ Head & Neck Surgery
 •Neoplasms of Head & Neck
 •Genetics
 •Genetic Disorders
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Microenvironmental Genomic Alterations and Clinicopathological Behavior in Head and Neck Squamous Cell Carcinoma

Frank Weber, MD; Yaomin Xu, MS; Li Zhang, PhD; Attila Patocs, MD, PhD; Lei Shen, PhD; Petra Platzer, PhD; Charis Eng, MD, PhD

JAMA. 2007;297:187-195.

Context  Carcinogens associated with head and neck squamous cell carcinoma (SCC) genesis should inflict genomic alterations not only on the epithelium but also the mesenchyme of the aerodigestive tract. Therefore, the apparently nonmalignant stroma surrounding the tumor epithelium can acquire genomic alterations and contribute to cancer initiation and progression.

Objectives  To determine compartment-specific loci of loss of heterozygosity or allelic imbalance (LOH/AI) and to identify which genomic alterations restricted to the stroma cell population contribute to aggressiveness of head and neck SCC disease.

Design, Setting, and Patients  Tumor epithelium and surrounding stroma were isolated from 122 US patients with oral cavity and oropharyngeal or hypopharyngeal SCC and subjected to whole-genome LOH/AI analysis using 366 microsatellite markers. Samples, collected between 2001 and 2004, were pulled and transferred in batches of 10 to 30 between 2002 and 2005. Laser capture microdissection DNA extraction and technical genotyping occurred on a rolling model between 2002 and November 2005.

Main Outcome Measures  Compartment-specific frequency and distribution of LOH/AI were determined, and hot spots of genomic alterations identified. Compartment-specific LOH/AI events were correlated with presenting clinicopathologic characteristics.

Results  Tumor-associated stroma of head and neck SCC from smokers were found to have a high degree of genomic alterations. A correlation between tumor aggressiveness could be found for a specific set of 5 loci. Three stroma-specific loci (D4S2417, D3S360, and D19555) were associated with tumor size (pT) and regional nodal metastases (pN). Furthermore, 2 epithelial-specific LOH/AI hot spots were positively correlated with pN status and clinical stage.

Conclusions  Stroma-specific genetic alterations are associated with smoking-related head and neck SCC genesis. These findings suggest novel prognostic or diagnostic biomarkers and identify potential new molecular targets for therapeutic and preventive intervention.


Author Affiliations: Genomic Medicine Institute and Lerner Research Institute (Drs Weber, Zhang, Patocs, Platzer, and Eng and Mr Xu), Section of Statistical Genetics, Department of Quantitative Health Sciences (Mr Xu and Dr Zhang), and Taussig Cancer Center (Dr Eng), Cleveland Clinic Foundation, Cleveland, Ohio; Division of Biostatistics, School of Public Health, Ohio State University, Columbus (Dr Shen); and Department of Statistics (Mr Xu), Department of Genetics (Dr Eng), and CASE Comprehensive Cancer Center (Dr Eng), Case Western Reserve University, Cleveland, Ohio.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clonal Mutations in the Cancer-Associated Fibroblasts: The Case against Genetic Coevolution
Campbell et al.
Cancer Res. 2009;69:6765-6769.
FULL TEXT  

Genomic Alterations in Tumor Stroma
Eng et al.
Cancer Res. 2009;69:6759-6764.
ABSTRACT | FULL TEXT  

Prognostic Significance of Stromal Platelet-Derived Growth Factor {beta}-Receptor Expression in Human Breast Cancer
Paulsson et al.
Am. J. Pathol. 2009;175:334-341.
ABSTRACT | FULL TEXT  

Mesenchymal Stem Cells: Flip Side of the Coin
Mishra et al.
Cancer Res. 2009;69:1255-1258.
ABSTRACT | FULL TEXT  

Microenvironmental Protection in Diffuse Large-B-Cell Lymphoma
Eng
NEJM 2008;359:2379-2381.
FULL TEXT  

Examination of Oral Cancer Biomarkers by Tissue Microarray Analysis
Choi et al.
Arch Otolaryngol Head Neck Surg 2008;134:539-546.
ABSTRACT | FULL TEXT  

Frequency of Germline Genomic Homozygosity Associated With Cancer Cases
Assie et al.
JAMA 2008;299:1437-1445.
ABSTRACT | FULL TEXT  

Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases
Patocs et al.
NEJM 2007;357:2543-2551.
ABSTRACT | FULL TEXT  

Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development
Bian et al.
Hum Mol Genet 2007;16:3128-3135.
ABSTRACT | FULL TEXT  

Genomic Instability Within Tumor Stroma and Clinicopathological Characteristics of Sporadic Primary Invasive Breast Carcinoma
Fukino et al.
JAMA 2007;297:2103-2111.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.